Fennec Pharmaceuticals Inc. Common Stock
FENC
XNAS
•
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market Cap
350M
Short interest (Jul 15)
1.8%
Net Short (Jul 27 ): 0.0%
Borrow Fee
0.41%
Available Shares
900K
Price Chart
Company Overview
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
Company Info
Exchange:
NASDAQ
Industry:
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
CIK:
0001211583
Asset Type:
CS
Market Data
Market Cap:
$347,022,929
Employees:
35
Status:
Active
Short Interest
Current Borrow Fee
0.41%
Range: 0.41% -
0.41%
Available Shares
900K
Range: 900K -
1.4M
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.